Tele: 561.316.3330
Breaking Medical Device News

Thursday, October 21, 2021


HomeMagnetic SensingUniversity Hospitals System Adopts Magseed Marker as Standard of Care for Localization...

University Hospitals System Adopts Magseed Marker as Standard of Care for Localization of Impalpable Breast Lesions


Global $45 Billion Endoscopy Market Insights & Forecasts to 2025

The global endoscopy market is predicted to reach US$45.28 billion in 2025, growing, at a CAGR of 7.50%, for the duration spanning 2021-2025.

Global Remote Monitoring Devices Market Research Report (2021 to 2026)

Global Remote Monitoring Devices Market size was estimated at USD 1,035.35 million in 2020, is expected to reach USD 1,170.22 million in 2021.

Research Efforts Fuel the Future of Global Obstructive Lung Disease Management Markets –

The "Global Obstructive Lung Disease Management Research Report" report has been added.

Global Electrophysiology Market (2021 to 2026) – Growth, Trends , COVID-19 Impact and Forecasts –

The Electrophysiology Market is expected to register a CAGR of 8.5% during the forecast period.

Endomag, the surgical guidance company, announced today that University Hospitals (UH), one of the leading healthcare systems in the US, providing high-quality, patient-centred cancer care at locations throughout Northeast Ohio, has expanded the use of its Magseed® marker technology at more sites within the UH system.

Magseed offers a simpler and more efficient system for localization of breast lesions than traditional hookwire techniques, improving patient experience and surgery scheduling. UH Seidman Cancer Center, UH Ahuja and UH Cleveland Medical campuses have been offering Magseed as the standard of care, carrying out over 450 successful procedures in the last 12 months. UH is now making Magseed available at other facilities to enhance the standard of breast care in the UH system.

The Magseed marker is the world’s first minimally-invasive surgical guidance system indicated to mark any soft tissue and long-term implantation. Magseed is a small, non-radioactive seed, smaller than a grain of rice, that helps surgeons locate impalpable breast cancer. Traditional hookwire methods require an additional visit to Radiology on the day of surgery, which can lead to delays in the OR. Furthermore, these techniques are often inefficient, invasive, inconvenient, and can be uncomfortable for the patient.

UH is dedicated to providing the highest quality of treatment for its patients and consistently strive for outstanding clinical outcomes. UH aims to maintain a positive experience for the patient from mammogram through to diagnosis and treatment, while supporting its physicians by supplying the most advanced diagnostic tools to ensure that the clinical care they provide is considered and delivered with confidence. UH started using Magseed at UH Seidman Cancer Center, UH Cleveland Medical Center and UH Ahuja Medical Center in March 2017 and is now making this technique available at more sites across the UH system, allowing all patients to experience the benefits.

Dr Donna Plecha, Director, Breast Imaging, Mammography at UH Cleveland Medical Center and Director, Breast Imaging at UH Seidman Cancer Center, said: ‘We’ve been using Magseed for nearly a year and can already see efficiency improvements in Radiology, and a better experience for our patients. Magseed allows us to mark the tumour at the same time as their pre-operative surgical clinic appointment, saving them an additional visit to the hospital, and by expanding Magseed availability across the UH system, we allow our patients the freedom to choose the UH facility that’s most convenient for them.’

Jenna Hundorfean, Manager, Breast Health Services at UH Cleveland Medical Center, said: ‘The start time in the OR sets the tone for the day. Wires often result in delays in Radiology, placing pressure on staff to keep successive surgeries on schedule. With Magseed, the Radiology department isn’t under pressure to get patients to the operating theatre in the morning, meaning we can start on time. Magseed decouples radiology and surgery, allowing the surgical day schedule to run independently of radiology procedures. Each surgical procedure also takes less time, resulting in increased efficiency, productivity and an improved experience for our patients.’

Dr Jill Dietz, Director of Breast Center Operations and Associate Professor of Surgery at UH Cleveland Medical Center, said: ‘Magseed offers significant advantages for both patient and surgeon. I am confident that it will enable UH to achieve its objectives, to build trusting patient-physician partnerships and improve clinical outcomes by providing the best possible care available. Not only is Magseed more likely to remove all the cancerous tissue, reducing the need for additional surgeries but in some patients, there is the option of choosing where to place the incision, allowing for a better cosmetic outcome.’




Children Achieve Time in Range Mirroring Well-controlled Adults for the 1st Time in Real-world Study of the MiniMed™ 780G System

"These results are extremely encouraging. Glycemic control has been much harder to achieve in children due to unpredictable factors common in this age group, including physical growth and development, hormonal changes and active lifestyles.

Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®

The publication documents two critically ill COVID-19 patients receiving a combined total of nine, six-hour Hemopurifier® treatment sessions.

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

For people with lymphedema, movement is important from both a clinical perspective and a quality-of-life perspective. These data illustrate the Dayspring treatment’s ability to provide that essential movement while still delivering the clinical outcomes we need from compression therapy.

Our Sister Publication: Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy